Halladay Benjamin 4
4 · Esperion Therapeutics, Inc. · Filed Mar 19, 2025
Insider Transaction Report
Form 4
Halladay Benjamin
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-03-18$1.48/sh−3,535$5,242→ 481,710 total
Footnotes (1)
- [F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.